Patients with AD may vary with respect to amyloid (e.g., the degree of diffuse vs neuritic plaques; extent of cerebral amyloid angiopathy), and the co-occurrence of common neurodegenerative pathologies (α-synuclein and TDP-43 pathology) or vascular brain pathology. The gene discussed is TARDBP; the disease is Alzheimer disease.